Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Hofseth BioCare ASA (HOFBF)

Compare
0.1550
0.0000
(0.00%)
At close: April 16 at 4:00:00 PM EDT
Loading Chart for HOFBF
  • Previous Close 0.0000
  • Open 0.1760
  • Bid --
  • Ask --
  • Day's Range 0.1760 - 0.1760
  • 52 Week Range 0.0950 - 0.2200
  • Volume 67,500
  • Avg. Volume 6
  • Market Cap (intraday) 79.441M
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

www.hofsethbiocare.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: HOFBF

View More

Performance Overview: HOFBF

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is OBX Total Return Index (OBX.OL) .

YTD Return

HOFBF
55.00%
OBX Total Return Index (OBX.OL)
3.24%

1-Year Return

HOFBF
29.55%
OBX Total Return Index (OBX.OL)
9.35%

3-Year Return

HOFBF
79.55%
OBX Total Return Index (OBX.OL)
17.90%

5-Year Return

HOFBF
77.77%
OBX Total Return Index (OBX.OL)
106.47%

Compare To: HOFBF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HOFBF

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    79.44M

  • Enterprise Value

    93.07M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.63

  • Price/Book (mrq)

    10.88

  • Enterprise Value/Revenue

    3.85

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -46.47%

  • Return on Assets (ttm)

    -17.96%

  • Return on Equity (ttm)

    -240.93%

  • Revenue (ttm)

    265.54M

  • Net Income Avi to Common (ttm)

    -123.41M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.58M

  • Total Debt/Equity (mrq)

    278.74%

  • Levered Free Cash Flow (ttm)

    21.85M

Research Analysis: HOFBF

View More

Company Insights: HOFBF

Research Reports: HOFBF

View More

People Also Watch